Health

Companies engaged in biotechnology, pharmaceuticals, research services, home healthcare, hospital operations, long‑term care, and the manufacture and supply of medical equipment and supplies. The sector also includes pharmaceutical retailers and providers of health‑information services. UK‑listed companies in this sector include AstraZeneca plc, GlaxoSmithKline plc, Smith & Nephew plc, Hikma Pharmaceuticals plc, ConvaTec Group plc, Spire Healthcare plc and EMIS Group plc.

GSK Plc’s Penmenvy vaccine backed by US Advisory Panel

GSK's Penmenvy vaccine is set to transform adolescent immunisation against meningococcal disease in the US, streamlining protection with fewer doses...

Breakthrough blood test set to transform testicular cancer detection

A groundbreaking blood test for testicular cancer, backed by actor Jack James Ryan, promises near-perfect accuracy and aims to transform early detection for men...

Discover how FluCamp is shaping the future of medical breakthroughs

Discover how FluCamp pioneers clinical trials, bridging lab discoveries and revolutionary treatments, ensuring safety and efficacy in modern medicine...

Cizzle Biotechnology launches its new corporate website

Cizzle Biotechnology Holdings plc has launched a new corporate website, enhancing access to vital information about its early cancer tests and growth strategy...

EDX Medical plc Game-Changing Blood Test Targets Early Detection of Testicular Cancer (Video)

Professor Sir Chris Evans, Founder and Chief Scientific Officer of EDX Medical, explains how this revolutionary blood test could reshape early diagnosis and monitoring..

Convatec Group welcomes CMS delay, ups FY25 InnovaMatrix® forecast

Convatec Group Plc celebrates the CMS's postponement of LCDs for diabetic foot ulcers, ensuring continued access to their trusted InnovaMatrix® for Medicare patients...

Poolbeg Pharma’s strategic move into a $10 billion oncology market

Poolbeg Pharma is innovating in oncology with POLB 001, a promising p38 MAP kinase inhibitor targeting Cytokine Release Syndrome, a critical complication in cancer therapies...

LPC joins forces with One Health Group to launch first surgical hub

One Health Group is set to transform orthopaedic care in the North of England with its first surgical hub, enhancing patient access to essential NHS services...

EDX Medical Group to launch highly accurate early detection test for testicular cancer

EDX Medical Group is set to launch TC100, a groundbreaking early detection test for testicular cancer in the UK, offering unparalleled accuracy for improved patient care...

Optima Health expands into Ireland with Cognate Health acquisition

Optima Health Plc has announced its acquisition of Cognate Health Limited for up to €9 million, expanding its footprint in the Irish occupational health sector...

A powerful push for prostate cancer awareness

Bishop David Walker's prostate cancer diagnosis highlights the importance of early detection and proactive healthcare, urging men to get tested before symptoms arise...

hVIVO delivers record 2024 results, revenue up 11.9% and EBITDA up 25.9%

hVIVO plc reports impressive audited results for 2024, showcasing a revenue increase and strong EBITDA growth in the human challenge clinical trial sector...

Nuformix reports positive NXP002 results in lung disease models

Nuformix plc announces promising re-analysis results for NXP002, targeting unmet needs in fibrosis and oncology, offering insights into new treatment pathways...

Unlocking growth through untapped talent at One Health Group

Under CEO Adam Binns, One Health Group has revolutionized healthcare through innovation, talent development, and strategic growth, achieving remarkable financial success...

AstraZeneca Plc Enhertu approved in the EU for HER2 breast cancer

AstraZeneca and Daiichi Sankyo's Enhertu gains EU approval for treating HR-positive, HER2-low metastatic breast cancer, offering new hope for patients...

AstraZeneca’s Imfinzi granted FDA approval in the US for bladder cancer

AstraZeneca's Imfinzi has received FDA approval as a groundbreaking treatment for muscle-invasive bladder cancer, significantly improving patient outcomes in clinical trials...

GSK Plc Nucala application for COPD accepted by EMA

GSK announces the EMA's review of Nucala (mepolizumab) as a potential add-on treatment for COPD, promising hope for 40 million patients battling this condition...

Haleon Plc publishes 2024 Annual Report

Haleon plc has released its Annual Report for 2024, detailing vital financial information and upcoming AGM plans. Discover key insights for investors now...

AstraZeneca Plc advances cell therapy ambition, acquiring EsoBiotec

AstraZeneca is set to transform cancer treatment by acquiring EsoBiotec, a leader in in vivo cell therapies that promise quicker, more effective patient care...

AstraZeneca Plc Imfinzi demonstrates improved EFS in early stage gastric cancer

The MATTERHORN Phase III trial reveals promising results for AstraZeneca's Imfinzi in enhancing event-free survival for patients with early-stage gastric cancer...
Search

Funds

Health

GSK Plc’s Penmenvy vaccine backed by US Advisory Panel

GSK's Penmenvy vaccine is set to transform adolescent immunisation against meningococcal disease in the US, streamlining protection with fewer doses...

Breakthrough blood test set to transform testicular cancer detection

A groundbreaking blood test for testicular cancer, backed by actor Jack James Ryan, promises near-perfect accuracy and aims to transform early detection for men...

Discover how FluCamp is shaping the future of medical breakthroughs

Discover how FluCamp pioneers clinical trials, bridging lab discoveries and revolutionary treatments, ensuring safety and efficacy in modern medicine...

Cizzle Biotechnology launches its new corporate website

Cizzle Biotechnology Holdings plc has launched a new corporate website, enhancing access to vital information about its early cancer tests and growth strategy...

EDX Medical plc Game-Changing Blood Test Targets Early Detection of Testicular Cancer (Video)

Professor Sir Chris Evans, Founder and Chief Scientific Officer of EDX Medical, explains how this revolutionary blood test could reshape early diagnosis and monitoring..

Convatec Group welcomes CMS delay, ups FY25 InnovaMatrix® forecast

Convatec Group Plc celebrates the CMS's postponement of LCDs for diabetic foot ulcers, ensuring continued access to their trusted InnovaMatrix® for Medicare patients...

Poolbeg Pharma’s strategic move into a $10 billion oncology market

Poolbeg Pharma is innovating in oncology with POLB 001, a promising p38 MAP kinase inhibitor targeting Cytokine Release Syndrome, a critical complication in cancer therapies...

LPC joins forces with One Health Group to launch first surgical hub

One Health Group is set to transform orthopaedic care in the North of England with its first surgical hub, enhancing patient access to essential NHS services...

EDX Medical Group to launch highly accurate early detection test for testicular cancer

EDX Medical Group is set to launch TC100, a groundbreaking early detection test for testicular cancer in the UK, offering unparalleled accuracy for improved patient care...

Optima Health expands into Ireland with Cognate Health acquisition

Optima Health Plc has announced its acquisition of Cognate Health Limited for up to €9 million, expanding its footprint in the Irish occupational health sector...

A powerful push for prostate cancer awareness

Bishop David Walker's prostate cancer diagnosis highlights the importance of early detection and proactive healthcare, urging men to get tested before symptoms arise...

hVIVO delivers record 2024 results, revenue up 11.9% and EBITDA up 25.9%

hVIVO plc reports impressive audited results for 2024, showcasing a revenue increase and strong EBITDA growth in the human challenge clinical trial sector...

Nuformix reports positive NXP002 results in lung disease models

Nuformix plc announces promising re-analysis results for NXP002, targeting unmet needs in fibrosis and oncology, offering insights into new treatment pathways...

Unlocking growth through untapped talent at One Health Group

Under CEO Adam Binns, One Health Group has revolutionized healthcare through innovation, talent development, and strategic growth, achieving remarkable financial success...

AstraZeneca Plc Enhertu approved in the EU for HER2 breast cancer

AstraZeneca and Daiichi Sankyo's Enhertu gains EU approval for treating HR-positive, HER2-low metastatic breast cancer, offering new hope for patients...

AstraZeneca’s Imfinzi granted FDA approval in the US for bladder cancer

AstraZeneca's Imfinzi has received FDA approval as a groundbreaking treatment for muscle-invasive bladder cancer, significantly improving patient outcomes in clinical trials...

GSK Plc Nucala application for COPD accepted by EMA

GSK announces the EMA's review of Nucala (mepolizumab) as a potential add-on treatment for COPD, promising hope for 40 million patients battling this condition...

Haleon Plc publishes 2024 Annual Report

Haleon plc has released its Annual Report for 2024, detailing vital financial information and upcoming AGM plans. Discover key insights for investors now...

AstraZeneca Plc advances cell therapy ambition, acquiring EsoBiotec

AstraZeneca is set to transform cancer treatment by acquiring EsoBiotec, a leader in in vivo cell therapies that promise quicker, more effective patient care...

AstraZeneca Plc Imfinzi demonstrates improved EFS in early stage gastric cancer

The MATTERHORN Phase III trial reveals promising results for AstraZeneca's Imfinzi in enhancing event-free survival for patients with early-stage gastric cancer...
Search

Funds

Health

FTSE 100

Funds